In HCC, the tumor marker alpha-fetoprotein (AFP) is increased, but it might be normal in
40% of cases. Increased AFP implies worse tumor differentiation. This study aimed to clarify …

Methods Peripheral blood samples from 56 HCC patients, obtained perioperatively, were
tested for the presence of AFP mRNA by nested reverse transcription-polymerase chain …

BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) can result from hepatitis C virus
(HCV)-related liver disease and is the fastest-growing cause of cancer-related death in the …

Background Total tumor volume (TTV) and serum alfa fetoprotein (AFP) level are important
risk factors linked with the high possibility of hepatocellular carcinoma (HCC) recurrence …

Hypothesis An elevated serum α-fetoprotein (AFP) level before orthotopic liver transplant
(OLT) is predictive of mortality after OLT for hepatocellular carcinoma (HCC). Design …

Serum alpha-fetoprotein (AFP) value is still not included in the consensus guidelines to
make decisions referring to liver transplantation (LT) for hepatocellular carcinoma (HCC) …

Aim: Lens culinaris agglutinin A‐reactive fraction of α‐fetoprotein (AFP‐L3) status has been
reported to be an independent prognostic factor in patients with hepatocellular carcinoma …

Background and aims The role of Alfa-fetoprotein (AFP) in the management of
hepatocellular carcinoma (HCC) is still debated, with differences in recommendations …

Background The postresection alpha-fetoprotein (AFP) in cirrhotic patients with
hepatocellular carcinoma (HCC) may predict overall survival (OS) and recurrence beyond …

Background This study aimed to investigate the role of the alpha fetoprotein (AFP) ratio
before and after curative resection in the prognosis of patients with hepatocellular carcinoma …